Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Go back to Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
(NASDAQ: CODX) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $ 
Open $0.38    52 Week Low $ 
Day High $0.38    P/E N/A 
Day Low $0.38    EPS $ 
Volume 98,127